Ligand validation:2QD1

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2QD1_IMD_D_901	20%	79%	0.216	0.82	0.27	0.59	-	-	0	0	100%	1
3HCO_IMD_B_2	88%	93%	0.093	0.97	0.24	0.25	-	-	1	0	100%	1
2QD2_IMD_B_425	86%	70%	0.108	0.976	0.49	0.67	-	-	3	0	100%	1
4KLR_IMD_A_501	73%	76%	0.137	0.964	0.07	0.87	-	-	0	0	100%	1
3HCP_IMD_A_424	71%	74%	0.114	0.933	0.44	0.57	-	-	0	0	100%	1
3HCN_IMD_B_925	68%	69%	0.093	0.904	0.64	0.56	-	-	1	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1
3NN1_IMD_B_243	99%	76%	0.049	0.986	0.35	0.59	-	-	0	0	100%	1
1W8K_IMD_A_1476	99%	44%	0.042	0.978	0.79	1.36	-	1	0	0	100%	1
2ASN_IMD_X_202	99%	67%	0.051	0.987	0.4	0.87	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.